Mark J. Shackleton

28.9k citations
121 papers · 20.1k · 11 hit papers · h-index 47

Impact in

    • Cancer Genomics and Diagnostics
  • Oncology top 0.1%
    • Cancer Cells and Metastasis
    • Cancer Immunotherapy and Biomarkers
    • Cancer-related Molecular Pathways

Papers in

    • Cancer Cells and Metastasis 18
    • Cancer Immunotherapy and Biomarkers 14
    • Cutaneous Melanoma Detection and Management 13
    • CAR-T cell therapy research 4
    • Cancer Genomics and Diagnostics 25

Mark J. Shackleton

114 papers receiving 19.7k citations

Mark J. Shackleton's Hit Papers

The repertoire of mutational signatures in human cancer 2020 · 2.3k citations
2.3k0+6+13Years since publication50010001.5k2.0k

Peers

Mark J. Shackleton
Comparison fields: 5 of 164
  • Cancer Research 6.0k
  • Oncology 9.1k
  • Molecular Biology 10.1k
  • Immunology 2.2k
  • Genetics 782
Replace Felicity Newell with:
Felicity Newell Australia
Stephen H. Kazakoff Australia
Michael C. J. Quinn United States
Conrad Leonard Australia
Isabelle Treilleux France
Kátia Nones Australia
Nobuyoshi Hiraoka Japan
Rosemary E. Zuna United States
Nikolajs Zeps Australia
Arndt Hartmann Germany
Mark J. Shackleton relative to Felicity Newell Australia Felicity Newell's profile →
Citations per field
00.5×1.6×
Felicity Newell · 1×
Citations per year

Countries citing papers authored by Mark J. Shackleton

Since Specialization
Citations

This map shows the geographic impact of Mark J. Shackleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Shackleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Shackleton more than expected).

Fields of papers citing papers by Mark J. Shackleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Shackleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Shackleton. The network helps show where Mark J. Shackleton may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark J. Shackleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark J. Shackleton Line = papers co-authored together Mark J. Shackleton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The repertoire of mutational signatures in human cancer
Hit paper breakdown →
20202339
2
Pan-cancer analysis of whole genomes
Hit paper breakdown →
20202109
3
Generation of a functional mammary gland from a single stem cell
Hit paper breakdown →
20061626
4
Efficient tumour formation by single human melanoma cells
Hit paper breakdown →
20081482
5
Purification and unique properties of mammary epithelial stem cells
Hit paper breakdown →
20061281
6
Whole–genome characterization of chemoresistant ovarian cancer
Hit paper breakdown →
20151233
7
Whole-genome landscapes of major melanoma subtypes
Hit paper breakdown →
20171099
8
Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution
Hit paper breakdown →
2009936
9
The evolutionary history of 2,658 cancers
Hit paper breakdown →
2020705
10
Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation
Hit paper breakdown →
2006689
11 2010495
12
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Hit paper breakdown →
2020476
13 2004377
14 2020317
15 2020301
16 2020293
17 2008279
18 2015268
19 2012252
20 2006237

About Mark J. Shackleton

Mark J. Shackleton is a scholar working on Oncology, Cancer Research, Immunology, Molecular Biology and Pathology and Forensic Medicine, having authored 121 papers that have together received 20.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (25 papers), Melanoma and MAPK Pathways (23 papers), Cancer Cells and Metastasis (18 papers), Immunotherapy and Immune Responses (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cutaneous Melanoma Detection and Management (13 papers), Genetic factors in colorectal cancer (8 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Cancer Research (6.0k citations), Oncology (9.1k citations), Molecular Biology (10.1k citations), Immunology (2.2k citations) and Genetics (782 citations). Mark J. Shackleton has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Elsa Quintana, Sean J. Morrison, François Vaillant, Julia Stingl, Timothy M. Johnson, Douglas Randall Fullen, Jane E. Visvader, Geoffrey J. Lindeman, Marie-Liesse Asselin-Labat and Michael S. Sabel. Their work appears in journals such as Nature Communications, Nature, Annals of Oncology, Oncogene and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact